| Alzheimer’s disease: an update and insights into pathophysiology MB Abubakar, KO Sanusi, A Ugusman, W Mohamed, H Kamal, ... Frontiers in aging neuroscience 14, 742408, 2022 | 197 | 2022 |
| MDMA: interactions with other psychoactive drugs WMY Mohamed, SB Hamida, JC Cassel, AP de Vasconcelos, BC Jones Pharmacology Biochemistry and Behavior 99 (4), 759-774, 2011 | 97 | 2011 |
| Effects of nutrition therapy on HbA1c and cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes A Mottalib, V Salsberg, BN Mohd-Yusof, W Mohamed, P Carolan, ... Nutrition journal 17, 1-10, 2018 | 95 | 2018 |
| Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease JJ Kim, D Vitale, DV Otani, MM Lian, K Heilbron, H Iwaki, J Lake, ... Nature genetics 56 (1), 27-36, 2024 | 83 | 2024 |
| Pharmacotherapy of Alzheimer’s disease: Seeking clarity in a time of uncertainty N Husna Ibrahim, MF Yahaya, W Mohamed, SL Teoh, CK Hui, J Kumar Frontiers in pharmacology 11, 261, 2020 | 75 | 2020 |
| Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease ALISWMYM MOHAMED SALAMA, MAHMOUD SOBH, MAHMOUD EMAM, AHMED ABDALLA, DINA ... EXPERIMENTAL AND THERAPEUTIC MEDICINE, 976-982, 2017 | 68 | 2017 |
| Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study M Rizig, S Bandres-Ciga, MB Makarious, OO Ojo, PW Crea, OV Abiodun, ... The Lancet Neurology 22 (11), 1015-1025, 2023 | 65 | 2023 |
| The promise of the zebrafish model for Parkinson’s disease: Today’s science and tomorrow’s treatment K Razali, N Othman, MH Mohd Nasir, AA Doolaanea, J Kumar, ... Frontiers in Genetics 12, 655550, 2021 | 65 | 2021 |
| Elevated serum α-synuclein autoantibodies in patients with parkinson’s disease relative to Alzheimer’s disease and controls A Shalash, M Salama, M Makar, T Roushdy, HH Elrassas, W Mohamed, ... Frontiers in Neurology 8, 720, 2017 | 63 | 2017 |
| Underrepresented populations in Parkinson's genetics research: current landscape and future directions AF Schumacher‐Schuh, A Bieger, O Okunoye, KY Mok, SY Lim, ... Movement Disorders 37 (8), 1593-1604, 2022 | 59 | 2022 |
| Depression following major life transitions in women: A review and theory AA Moustafa, JJ Crouse, MM Herzallah, M Salama, W Mohamed, B Misiak, ... Psychological reports 123 (5), 1501-1517, 2020 | 56 | 2020 |
| Arab and Muslim contributions to modern neuroscience WMY Mohamed IBRO History of Neuroscience, 2008 | 46 | 2008 |
| C-Abl inhibition; a novel therapeutic target for Parkinson's disease AI Abushouk, A Negida, RA Elshenawy, H Zein, AM Hammad, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2018 | 44 | 2018 |
| Developing expertise in bioinformatics for biomedical research in Africa TK Karikari, E Quansah, WMY Mohamed Applied & translational genomics 6, 31-34, 2015 | 43 | 2015 |
| Mitochondrial complex I inhibition as a possible mechanism of chlorpyrifos induced neurotoxicity M Salama, D El-Morsy, M El-Gamal, O Shabka, WMY Mohamed Annals of neurosciences 21 (3), 85, 2014 | 41 | 2014 |
| Metformin therapy attenuates pro-inflammatory microglia by inhibiting NF-κB in cuprizone demyelinating mouse model of multiple sclerosis M Abdi, P Pasbakhsh, M Shabani, S Nekoonam, A Sadeghi, F Fathi, ... Neurotoxicity research 39, 1732-1746, 2021 | 40 | 2021 |
| A comparative study of three onshore wind turbine foundation solutions W Mohamed, PE Austrell Computers and Geotechnics 94, 46-57, 2018 | 39 | 2018 |
| Investigation of redox status in chronic cerebral hypoperfusion-induced neurodegeneration in rats AK Saxena, SS Abdul-Majeed, S Gurtu, WMY Mohamed Applied & Translational Genomics 5, 30-32, 2015 | 39 | 2015 |
| Genetic underpinnings in Alzheimer’s disease–a review AA Moustafa, M Hassan, DH Hewedi, I Hewedi, JK Garami, H Al Ashwal, ... Reviews in the Neurosciences 29 (1), 21-38, 2017 | 33 | 2017 |
| Neurotoxin-induced rodent models of Parkinson’s disease: benefits and drawbacks M El-Gamal, M Salama, LE Collins-Praino, I Baetu, AM Fathalla, ... Neurotoxicity research 39, 897-923, 2021 | 31 | 2021 |